Investing in dividend stocks is a great strategy for many reasons, including the potential they offer you to significantly boost your long-term returns by automatically reinvesting their payouts. Furthermore,...
Since Eli Lilly reported third-quarter earnings on Oct. 30, its shares have had a prolonged sell-off.
News of a fresh licensing deal by a well-capitalized rival sent Viking Therapeutics (NASDAQ: VKTX) stock into something of a tailspin this week. According to data compiled by S&P Global Market Intelligence,...
The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +1.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.23%. March E-mini S&P...
On the analyst front, Citi and UBS both described Novo’s readout as favorable for Eli Lilly.
Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for.
The S&P 500 Index ($SPX ) (SPY ) today is up +1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.08%. March E-mini S&P futures (ESH25...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. March E-mini S&P futures...
It isn't easy to find steady and reliable dividend payers in the pharmaceutical industry. The key reason is simple: Drug development is a frequently laborious and expensive process that can swallow vast...
Eli Lilly just gave investors several reasons to cheer.